Losan Pharma

Executive Summary

Losan Pharma GmbH is a German CDMO with over 30 years of expertise in drug development and manufacturing, focusing on improving API performance, stability, and bioavailability. The company offers end-to-end services for solid, semi-solid, and liquid dosage forms. Despite its established presence, Losan Pharma remains private and relatively under the radar, with limited public information on recent financial performance or pipeline. Its strengths lie in its specialized technologies for bioavailability enhancement and its ability to serve both small and large pharma clients. However, the competitive CDMO landscape and lack of scale compared to larger players may limit growth visibility. Overall, Losan Pharma represents a niche but stable player in the contract manufacturing space, with potential for steady expansion driven by increasing outsourcing demand.

Upcoming Catalysts (preview)

• 2026Expansion of manufacturing capacity or new facility announcement60% success
• TBDStrategic partnership or long-term supply agreement with a major pharma40% success
• TBDLaunch of a novel drug delivery platform or technology30% success